Previous 10 | Next 10 |
home / stock / phguf / phguf news
Pharming Group N.V. press release (OTCPK:PHGUF): FY GAAP EPS of €0.02. Revenue of €198.9M (-6.3% Y/Y). For further details see: Pharming Group N.V. GAAP EPS of €0.02, revenue of €198.9M
Pharming Group N.V. (PHGUF) Q3 2021 Results Conference Call October 28, 2021 07:30 AM ET Company Participants Sijmen de Vries - CEO Dr. Anurag Relan - Chief Medical Officer Jeroen Wakkerman - CFO Conference Call Participants Hartaj Singh - Oppenheimer & Co. Joe Pantginis - H.C. Wainright ...
Pharming Group N.V. (PHGUF) Q2 2021 Earnings Conference Call August 05, 2021 01:00 PM ET Company Participants Sijmen De Vries - Chief Executive Officer Jeroen Wakkerman - Chief Financial Officer Conference Call Participants Joe Pantginis - Wainwright Alex Cogut - Kempen Christian Glennie - St...
Orchard Therapeutics (ORTX) and Pharming Group (PHAR) announce a strategic collaboration to research, develop, manufacture and commercialize OTL-105, an investigational ex vivo autologous hematopoietic stem cell ((HSC)) gene therapy for the treatment of hereditary angioedema ((HAE)), a rare d...
Pharming Group made the first ever genetically modified animal in the world. Pharming Group's Ruconest has multiple complementary use-cases, apart from treating acute HAE attacks. Recent developments surrounding COVID-19 showcase that mutations continue to be a risk for reopening ...
Pharming Group's stock has had a lacklustre performance since it announced Ruconest might be effective at treating severe COVID-19 cases. Pharming Group's CEO announced that the company is planning to use genetically manipulated cows to expand production of Ruconest significantly. ...
LEIDEN, Netherlands , Aug. 17, 2020 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) today announces the publication of data in the peer-reviewed journal, Frontiers in Immunology, from a compassionate use programme of five patients with co...
Delivered 14% increase in revenue, 31% increase in operating profit and 33% increase in net profit year-on-year LEIDEN, Netherlands , July 30, 2020 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) presents its (unaudited) financial report f...
LEIDEN, Netherlands , May 20, 2020 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) announces that at its Annual General Meeting of shareholders (AGM), held today, the proposals related to remuneration were withdrawn and all other proposal...
LEIDEN, Netherlands , May 16, 2020 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) today supports "hae-day :-)", the global awareness day for hereditary angioedema (HAE), a rare life-threatening condition. On 16 May every year, the hae day ...
News, Short Squeeze, Breakout and More Instantly...
Pharming Group Nv Ord Company Name:
PHGUF Stock Symbol:
OTCMKTS Market:
Pharming Group Nv Ord Website:
Leiden, the Netherlands, July 18, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) second quarter and first half 2024 financial results, for the period ended June 30, on Thursday, August 1, 2024. ...
Leiden, the Netherlands, June 3, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conferences in the month of June: Jefferies Healthcare Conference, New ...
Leiden, the Netherlands, May 21, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM/Nasdaq: PHAR) announces that at its Annual General Meeting of Shareholders (AGM) held today, all proposals were approved. The shareholders approved the proposa...